ResMed (RMD) PT Raised to $76 at Barclays

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 1/29/2023

1. INTC
2. TSLA
3. SPY
4. V
5. LCID

6. HAS
7. CVX
8. FE
9. MA
10. AXP

Price: $224.59 -3.26%

Rating Summary:
12 Buy, 10 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
Up: 15 | Down: 21 | New: 16

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Barclays raised its price target on ResMed (NYSE: RMD) to $76.00 (from $70.00) while maintaining a Underweight rating.

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!